Hepatogenic differentiation of mesenchymal stem cells in a rat model of thioacetamide-induced liver cirrhosis

Cell Biology International

Volumn 36, Issue 3, 2012, Pages 279-288

  Hwang, Shin ^a   Hong, Hea Nam ^a   Kim, Hee Sung ^a   Park, Se Ra ^a   Won, You Jin ^a   Choi, Sang Tae ^b   Choi, Dongho ^c   Lee, Sung Gyu ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Differentiation; Hepatocyte; Liver cirrhosis; Mesenchymal stem cell (MSC); Rat Model; Thioacetamide (TAA)

Indexed keywords

CYTOKERATIN 19; GLYCOGEN; SCATTER FACTOR; THIOACETAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL REGENERATION; CONTROLLED STUDY; HEPATOCYTE LIKE CELL; HISTOLOGY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER PARENCHYMA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; STELLATE CELL; WESTERN BLOTTING;

ANIMALS; CELL DIFFERENTIATION; HEPATOCYTES; LIVER; LIVER CIRRHOSIS; MALE; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; THIOACETAMIDE;

RATTUS;

EID: 84859230268     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110325     Document Type: Article

References (43)

1. Alison MR, Choong C, Lim S. Application of liver stem cells for cell therapy. Semin Cell Dev Biol 2007;18:819-26.
2. Alison MR, Islam S, Lim S. Stem cells in liver regeneration, fibrosis and cancer: the good, the bad and the ugly. J Pathol 2009;217:282-98.
3. Aurich I, Mueller LP, Aurich H, Luetzkendorf, J, Tisljar, K, Dollinger, MM et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut 2007;56:405-15.
4. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000;290:1775-9.
5. Carvalho AB, Quintanilha LF, Dias JV, Paredes BD, Mannheimer EG, Carvalho FG et al. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 2008; 26:1307-314.
6. Constantinou MA, Theocharis SE, Mikros E. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats. Toxicol Appl Pharmacol 2007;218:11-9.
7. Dashti H, Jeppsson B, Hägerstrand I, Hultberg B, Srinivas U, Abdulla M et al. Early biochemical and histological changes in rats exposed to a single injection of thioacetamide. Pharmacol Toxicol 1987;60:171-4.
8. Dashti H, Jeppsson B, Hagerstrand I, Hultberg B, Srinivas U, Abdulla M, Bengmark S. Thioacetamide- and carbon tetrachloride-induced liver cirrhosis. Eur Surg Res 1989;21:83-91.
9. Dashti H, Behbehani A, Abul H, Hussain T, Madda P. Alterations of trace elements in kidney, spleen and lungs in treated and untreated experimental liver cirrhosis. J R Coll Surg Edinb 1995;40:173-9.
10. Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liverbased metabolic disorders. J Inherit Metab Dis 2006;29:431-5.
11. Eckersley-Maslin MA, Warner FJ, Grzelak CA, McCaughan GW, Shackel NA. Bone marrow stem cells and the liver: are they relevant? J Gastroenterol Hepatol 2009;24:1608-616.
12. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachlorideinduced liver fibrosis in mice. Transplantation 2004;78:83-8.
13. Fürst G, Schulte am Esch J, Poll LW, Hosch SB, Fritz LB, Klein M et al. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Radiology 2007;243:171-9.
14. Gaudio E, Carpino G, Cardinale V, Franchitto A, Onori P, Alvaro D. New insights into liver stem cells. Dig Liver Dis 2009;41:455-62.
15. Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl 2010;16:118-29.
16. Gribilas G, Zarros A, Zira A, Giaginis C, Tsourouflis G, Liapi C et al. Involvement of hepatic stimulator substance in experimentally induced fibrosis and cirrhosis in the rat. Dig Dis Sci 2009;54:2367-76.
17. Hardjo M, Miyazaki M, Sakaguchi M, Masaka T, Ibrahim S, Kataoka K, Huh NH. Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow. Cell Transplant 2009;18:89-99.
18. Harris RG, Herzog EL, Bruscia EM, Grove JE, Van Arnam JS, Krause DS. Lack of a fusion requirement for development of bone marrowderived epithelia. Science 2004;305:90-93.
19. Ismail A, Fouad O, Abdelnasser A, Chowdhury A, Selim A. Stem cell therapy improves the outcome of liver resection in cirrhotics. J Gastrointest Cancer 2010;41:17-23.
20. Kanazawa Y, Verma IM. Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver. Proc Natl Acad Sci USA 2003;100(SUPPL. 1):11850-53.
21. Kim S, Kim HS, Lee E, Kim HO. In vivo hepatic differentiation potential of human cord blood-derived mesenchymal stem cells. Int J Mol Med 2011;27:701-706.
22. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109:1543-9.
23. Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 2007;22:S73-8.
24. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001;105:369-77.
25. Kreft B, Dombrowski F, Block W, Bachmann R, Pfeifer U, Schild H. Evaluation of different models of experimentally induced liver cirrhosis for MRI research with correlation to histopathologic findings. Invest Radiol 1999;34:360-66.
26. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008;134:2111-21, e1-3.
27. Magness ST, Bataller R, Yang L, Brenner DA. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 2004;40:1151-9.
28. Mangipudy RS, Chanda S, Mehendale HM. Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ Health Perspect 1995;103:260-67.
29. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000;290:1779-82.
30. Moriya K, Yoshikawa M, Ouji Y, Saito K, Nishiofuku M, Matsuda R et al. Embryonic stem cells reduce liver fibrosis in CCl4-treated mice. Int J Exp Pathol 2008;89:401-409.
31. Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, Nakamura T et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 2006;44:742-8.
32. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-70.
33. Pulavendran S, Vignesh J, Rose C. Differential anti-inflammatory and anti-fibrotic activity of transplanted mesenchymal vs. hematopoietic stem cells in carbon tetrachloride-induced liver injury in mice. Int Immunopharmacol 2010;10:513-9.
34. Sadowski D, Kiel ME, Apicella M, Arriola AG, Chen CP, McKinnon RD. Teratogenic potential in cultures optimized for oligodendrocyte development from mouse embryonic stem cells. Stem Cells Dev 2010;19:1343-53.
35. Salguero Palacios R, Roderfeld M, Hemmann S, Rath T, Atanasova S, Tschuschner A et al. Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Lab Invest 2008;88:1192-203.
36. Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005;106:756-63.
37. Seo MJ, Suh SY, Bae YC, Jung JS. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 2005;328:258-64.
38. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005;111:150-56.
39. Strom SC, Bruzzone P, Cai H, Ellis E, Lehmann T, Mitamura K, Miki T. Hepatocyte transplantation: clinical experience and potential for future use. Cell Transplant 2006;15(SUPPL. 1):S105-S110.
40. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008;47:1634-43.
41. Vogels BA, Maas MA, Bosma A, Chamuleau RA. Significant improvement of survival by intrasplenic hepatocyte transplantation in totally hepatectomized rats. Cell Transplant 1996;5:369-78.
42. Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, Li SN, Xiang P. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 2005;11:3431-40.
43. Zheng JF, Liang LJ. Intra-portal transplantation of bone marrow stromal cells ameliorates liver fibrosis in mice. Hepatobiliary Pancreat Dis Int 2008;7:264-70.